–
BridgeBio Oncology Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY24 to FY25
millions USD
FY23:
FY24:
159
FY25:
432
(positive)
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
5.61
FY25:
16.0
Total assets
Change from FY23 to FY25
millions USD
FY23:
0.33
FY24:
164
FY25:
448
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.40
FY24:
19.6
FY25:
35.0
(negative)
millions USD
FY23:
0
FY24:
0
FY25:
2.24
(positive)
Change from FY23 to FY25
millions USD
FY23:
−0.06
FY24:
−179
FY25:
411
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
0.33
FY24:
–
FY25:
448
All amounts in millions USD